TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2073721
log Bayes Factor = 55.1867
Chromosome 6   position 31,129,616  (GRCh37) Explore rs2073721 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.001 0.999
E11.9 Without complications
0.000 0.001 0.999
E83.1 Disorders of iron metabolism
0.999 0.001 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.001 0.999
L40.9 Psoriasis, unspecified
0.000 0.001 0.999
G35 Multiple sclerosis
0.994 0.006 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.009 0.991
E05.9 Thyrotoxicosis, unspecified
0.000 0.009 0.991
E14 Unspecified diabetes mellitus
0.000 0.036 0.964
E78.0 Pure hypercholesterolaemia
0.000 0.045 0.955
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.049 0.951
E70-E90 Metabolic disorders
0.000 0.053 0.946
E07 Other disorders of thyroid
0.000 0.110 0.890
E14.9 Without complications
0.000 0.112 0.888
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.117 0.883
L40 Psoriasis
0.000 0.125 0.875
E11.0 With coma
0.000 0.142 0.858
E78.8 Other disorders of lipoprotein metabolism
0.000 0.166 0.834
E14.3 With ophthalmic complications
0.000 0.186 0.814
E10.8 With unspecified complications
0.000 0.189 0.811
E07.9 Disorder of thyroid, unspecified
0.000 0.189 0.811
E11.2 With renal complications
0.000 0.193 0.807
E10.3 With ophthalmic complications
0.000 0.194 0.806
G35-G37 Demyelinating diseases of the central nervous system
0.800 0.200 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.206 0.794
E78.2 Mixed hyperlipidaemia
0.000 0.220 0.780
E10.6 With other specified complications
0.000 0.221 0.779
E11.1 With ketoacidosis
0.000 0.227 0.773
E03.8 Other specified hypothyroidism
0.000 0.227 0.773
E14.5 With peripheral circulatory complications
0.000 0.247 0.753
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.248 0.752
G37 Other demyelinating diseases of central nervous system
0.750 0.250 0.000
L40.5 Arthropathic psoriasis
0.000 0.254 0.746
L40.0 Psoriasis vulgaris
0.000 0.263 0.737
E14.4 With neurological complications
0.000 0.265 0.735
E79 Disorders of purine and pyrimidine metabolism
0.000 0.266 0.734
E14.6 With other specified complications
0.000 0.272 0.728
E74 Other disorders of carbohydrate metabolism
0.000 0.273 0.727
L40.8 Other psoriasis
0.000 0.279 0.721
E14.2 Withrenal complications
0.000 0.281 0.719
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.284 0.716
E78.4 Other hyperlipidaemia
0.000 0.284 0.716
E40-E46 Malnutrition
0.000 0.286 0.713
E05.5 Thyroid crisis or storm
0.000 0.289 0.710
E05.4 Thyrotoxicosis factitia
0.000 0.289 0.710
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.289 0.710
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.289 0.710
G37.9 Demyelinating disease of central nervous system, unspecified
0.707 0.293 0.000
E78.1 Pure hyperglyceridaemia
0.000 0.305 0.695
E10.0 With coma
0.000 0.309 0.691
E14.7 With multiple complications
0.000 0.309 0.691
E14.0 With coma
0.000 0.309 0.691
E13 Other specified diabetes mellitus
0.000 0.311 0.689
E14.1 With ketoacidosis
0.000 0.316 0.684
E10.1 With ketoacidosis
0.000 0.318 0.682
E78.3 Hyperchylomicronaemia
0.000 0.318 0.682
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.321 0.679
E77 Disorders of glycoprotein metabolism
0.000 0.321 0.679
E76 Disorders of glycosaminoglycan metabolism
0.000 0.321 0.679
E72 Other disorders of amino-acid metabolism
0.000 0.321 0.679
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.321 0.679
E70 Disorders of aromatic amino-acid metabolism
0.000 0.321 0.679
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.321 0.679
K90 Intestinal malabsorption
0.000 0.324 0.676
E83 Disorders of mineral metabolism
0.634 0.325 0.040
E78.6 Lipoprotein deficiency
0.000 0.328 0.672
L40.1 Generalised pustular psoriasis
0.000 0.339 0.661
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.342 0.658
E84 Cystic fibrosis
0.000 0.352 0.648
E16 Other disorders of pancreatic internal secretion
0.000 0.354 0.646
E11.8 With unspecified complications
0.000 0.358 0.642
E14.8 With unspecified complications
0.000 0.362 0.638
E07.1 Dyshormogenetic goitre
0.000 0.362 0.638
E07.0 Hypersecretion of calcitonin
0.000 0.362 0.638
E07.8 Other specified disorders of thyroid
0.000 0.363 0.637
L40.2 Acrodermatitis continua
0.000 0.372 0.628
E03.1 Congenital hypothyroidism without goitre
0.000 0.372 0.627
E10.2 With renal complications
0.000 0.378 0.622
G36 Other acute disseminated demyelination
0.619 0.381 0.000
L40.4 Guttate psoriasis
0.000 0.383 0.617
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.387 0.613
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.394 0.605
E05.8 Other thyrotoxicosis
0.000 0.395 0.604
E10.5 With peripheral circulatory complications
0.000 0.399 0.601
G37.8 Other specified demyelinating diseases of central nervous system
0.597 0.403 0.000
E78.5 Hyperlipidaemia, unspecified
0.000 0.407 0.593
E80.6 Other disorders of bilirubin metabolism
0.000 0.415 0.584
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.418 0.581
C83.3 Large cell (diffuse)
0.000 0.419 0.581
E15 Nondiabetic hypoglycaemic coma
0.000 0.431 0.569
E73 Lactose intolerance
0.000 0.431 0.569
E80.2 Other porphyria
0.000 0.432 0.567
E80.4 Gilbert's syndrome
0.000 0.443 0.557
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.461 0.539
E80.5 Crigler-Najjar syndrome
0.000 0.461 0.539
E80.3 Defects of catalase and peroxydase
0.000 0.461 0.539
E80.0 Hereditary erythropoietic porphyria
0.000 0.461 0.539
G37.5 Concentric sclerosis [Balo]
0.538 0.462 0.000
G37.4 Subacute necrotising myelitis
0.538 0.462 0.000
G37.2 Central pontine myelinolysis
0.538 0.462 0.000
G37.1 Central demyelination of corpus callosum
0.538 0.462 0.000
G37.0 Diffuse sclerosis
0.538 0.462 0.000
E88 Other metabolic disorders
0.000 0.466 0.534
E11.5 With peripheral circulatory complications
0.000 0.466 0.534
E10.4 With neurological complications
0.000 0.470 0.530
E80.1 Porphyria cutanea tarda
0.000 0.471 0.529
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.474 0.526
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.474 0.526
E79.1 Lesch-Nyhan syndrome
0.000 0.474 0.526
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.477 0.523
E83.3 Disorders of phosphorus metabolism
0.507 0.479 0.015
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.479 0.521
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.479 0.521
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.479 0.521
E74.2 Disorders of galactose metabolism
0.000 0.479 0.521
E74.1 Disorders of fructose metabolism
0.000 0.479 0.521
E85 Amyloidosis
0.000 0.479 0.521
E83.9 Disorder of mineral metabolism, unspecified
0.494 0.480 0.026
E16.2 Hypoglycaemia, unspecified
0.000 0.482 0.518
L40-L45 Papulosquamous disorders
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.512 0.488 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.488 0.512
E45 Retarded development following protein-energy malnutrition
0.000 0.488 0.512
E43 Unspecified severe protein-energy malnutrition
0.000 0.488 0.512
E42 Marasmic kwashiorkor
0.000 0.488 0.512
E41 Nutritional marasmus
0.000 0.488 0.512
E40 Kwashiorkor
0.000 0.488 0.512
E46 Unspecified protein-energy malnutrition
0.000 0.491 0.509
L40.3 Pustulosis palmaris et plantaris
0.000 0.492 0.507
E16.1 Other hypoglycaemia
0.000 0.505 0.495
E13.9 Without complications
0.000 0.506 0.494
E11.6 With other specified complications
0.000 0.506 0.494
E13.8 With unspecified complications
0.000 0.506 0.494
E13.7 With multiple complications
0.000 0.506 0.494
E13.6 With other specified complications
0.000 0.506 0.494
E13.5 With peripheral circulatory complications
0.000 0.506 0.494
E13.4 With neurological complications
0.000 0.506 0.494
E13.2 With renal complications
0.000 0.506 0.494
E13.1 With ketoacidosis
0.000 0.506 0.494
E13.0 With coma
0.000 0.506 0.494
G36.0 Neuromyelitis optica [Devic]
0.489 0.511 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.513 0.486
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.513 0.486
E70.3 Albinism
0.000 0.513 0.486
E70.2 Disorders of tyrosine metabolism
0.000 0.513 0.486
E70.1 Other hyperphenylalaninaemias
0.000 0.513 0.486
E70.0 Classical phenylketonuria
0.000 0.513 0.486
E71.3 Disorders of fatty-acid metabolism
0.000 0.513 0.486
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.513 0.486
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.513 0.486
E71.0 Maple-syrup-urine disease
0.000 0.513 0.486
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.513 0.486
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.513 0.486
E72.5 Disorders of glycine metabolism
0.000 0.513 0.486
E72.4 Disorders of ornithine metabolism
0.000 0.513 0.486
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.513 0.486
E72.2 Disorders of urea cycle metabolism
0.000 0.513 0.486
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.513 0.486
E72.0 Disorders of amino-acid transport
0.000 0.513 0.486
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.513 0.486
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.513 0.486
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.513 0.486
E76.2 Other mucopolysaccharidoses
0.000 0.513 0.486
E76.1 Mucopolysaccharidosis, type II
0.000 0.513 0.486
E76.0 Mucopolysaccharidosis, type I
0.000 0.513 0.486
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.513 0.486
E77.8 Other disorders of glycoprotein metabolism
0.000 0.513 0.486
E77.1 Defects in glycoprotein degradation
0.000 0.513 0.486
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.513 0.486
K90.3 Pancreatic steatorrhoea
0.000 0.515 0.484
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.515 0.484
K90.1 Tropical sprue
0.000 0.515 0.484
E83.8 Other disorders of mineral metabolism
0.455 0.516 0.029
E83.2 Disorders of zinc metabolism
0.455 0.516 0.029
E83.0 Disorders of copper metabolism
0.455 0.516 0.029
K90.8 Other intestinal malabsorption
0.000 0.525 0.475
E75.6 Lipid storage disorder, unspecified
0.000 0.528 0.472
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.528 0.472
E75.3 Sphingolipidosis, unspecified
0.000 0.528 0.472
E75.2 Other sphingolipidosis
0.000 0.528 0.472
E75.1 Other gangliosidosis
0.000 0.528 0.472
E75.0 GM2 gangliosidosis
0.000 0.528 0.472
K90.9 Intestinal malabsorption, unspecified
0.000 0.531 0.469
E13.3 With ophthalmic complications
0.000 0.535 0.465
E84.8 Cystic fibrosis with other manifestations
0.000 0.535 0.465
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.535 0.465
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.535 0.465
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.535 0.465
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.536 0.464
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.536 0.464
E16.4 Abnormal secretion of gastrin
0.000 0.536 0.464
E16.3 Increased secretion of glucagon
0.000 0.536 0.464
E74.0 Glycogen storage disease
0.000 0.540 0.459
E75.5 Other lipid storage disorders
0.000 0.549 0.451
G36.9 Acute disseminated demyelination, unspecified
0.444 0.556 0.000
G36.8 Other specified acute disseminated demyelination
0.444 0.556 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.444 0.556 0.000
E11.4 With neurological complications
0.000 0.562 0.438
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.565 0.435
E84.9 Cystic fibrosis, unspecified
0.000 0.566 0.434
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.567 0.433
E83.5 Disorders of calcium metabolism
0.429 0.568 0.003
L42 Pityriasis rosea
0.000 0.587 0.413
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.587 0.413
E88.2 Lipomatosis, not elsewhere classified
0.000 0.590 0.410
L43 Lichen planus
0.000 0.591 0.409
E73.8 Other lactose intolerance
0.000 0.592 0.408
E73.1 Secondary lactase deficiency
0.000 0.592 0.408
E73.0 Congenital lactase deficiency
0.000 0.592 0.408
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.594 0.406
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.595 0.405
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.596 0.403
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.599 0.401
C85.1 B-cell lymphoma, unspecified
0.000 0.599 0.401
E89.4 Postprocedural ovarian failure
0.000 0.606 0.394
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.612 0.388
E88.9 Metabolic disorder, unspecified
0.000 0.617 0.383
E88.8 Other specified metabolic disorders
0.000 0.617 0.383
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.623 0.377
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.625 0.375
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.625 0.375
E89.5 Postprocedural testicular hypofunction
0.000 0.625 0.375
E89.1 Postprocedural hypoinsulinaemia
0.000 0.625 0.375
E88.3 Tumour lysis syndrome
0.000 0.626 0.374
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.626 0.373
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.626 0.373
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.626 0.373
E85.9 Amyloidosis, unspecified
0.000 0.627 0.373
L44 Other papulosquamous disorders
0.000 0.631 0.369
L41 Parapsoriasis
0.000 0.631 0.369
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.631 0.369
E44.1 Mild protein-energy malnutrition
0.000 0.633 0.367
E44.0 Moderate protein-energy malnutrition
0.000 0.633 0.367
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.634 0.366
E06 Thyroiditis
0.001 0.638 0.361
E89.3 Postprocedural hypopituitarism
0.000 0.639 0.361
E85.8 Other amyloidosis
0.000 0.648 0.352
L43.9 Lichen planus, unspecified
0.000 0.650 0.350
E20-E35 Disorders of other endocrine glands
0.000 0.656 0.344
E65-E68 Obesity and other hyperalimentation
0.000 0.662 0.338
E85.4 Organ-limited amyloidosis
0.000 0.668 0.332
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.670 0.330
C83.7 Burkitt's tumour
0.000 0.670 0.329
E50-E64 Other nutritional deficiencies
0.000 0.673 0.327
C81 Hodgkin's disease
0.000 0.674 0.325
E89.2 Postprocedural hypoparathyroidism
0.000 0.676 0.323
C82.2 Large cell, follicular
0.000 0.677 0.323
E85.3 Secondary systemic amyloidosis
0.001 0.686 0.313
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.689 0.311
E83.4 Disorders of magnesium metabolism
0.292 0.689 0.019
C83.6 Undifferentiated (diffuse)
0.000 0.690 0.310
C83.5 Lymphoblastic (diffuse)
0.000 0.690 0.310
C83.4 Immunoblastic (diffuse)
0.000 0.690 0.310
C83.2 Mixed small and large cell (diffuse)
0.000 0.690 0.310
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.695 0.304
E73.9 Lactose intolerance, unspecified
0.001 0.701 0.298
C82.3 Follicular lymphoma grade IIIa
0.000 0.703 0.297
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.704 0.296
C85.0 Lymphosarcoma
0.000 0.704 0.296
L43.3 Subacute (active) lichen planus
0.000 0.706 0.294
L43.2 Lichenoid drug reaction
0.000 0.706 0.294
L43.1 Bullous lichen planus
0.000 0.706 0.294
L43.0 Hypertrophic lichen planus
0.000 0.706 0.294
C81.9 Hodgkin's disease, unspecified
0.000 0.707 0.293
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.709 0.290
C86 Other specified types of T/NK-cell lymphoma
0.000 0.709 0.290
C83.1 Small cleaved cell (diffuse)
0.000 0.710 0.289
E28 Ovarian dysfunction
0.000 0.711 0.289
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.715 0.285
E23 Hypofunction and other disorders of pituitary gland
0.000 0.717 0.283
C82.6 Cutaneous follicle centre lymphoma
0.000 0.722 0.278
C82.5 Diffuse follicle centre lymphoma
0.000 0.722 0.278
C82.4 Follicular lymphoma grade IIIb
0.000 0.722 0.278
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.729 0.271
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.733 0.267
E24 Cushing's syndrome
0.000 0.734 0.266
L41.9 Parapsoriasis, unspecified
0.000 0.735 0.265
L41.8 Other parapsoriasis
0.000 0.735 0.265
L41.5 Retiform parapsoriasis
0.000 0.735 0.265
L41.4 Large plaque parapsoriasis
0.000 0.735 0.265
L41.3 Small plaque parapsoriasis
0.000 0.735 0.265
L41.2 Lymphomatoid papulosis
0.000 0.735 0.265
L41.1 Pityriasis lichenoides chronica
0.000 0.735 0.265
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.735 0.265
L44.9 Papulosquamous disorder, unspecified
0.000 0.735 0.265
L44.8 Other specified papulosquamous disorders
0.000 0.735 0.265
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.735 0.265
L44.3 Lichen ruber moniliformis
0.000 0.735 0.265
L44.2 Lichen striatus
0.000 0.735 0.265
L44.1 Lichen nitidus
0.000 0.735 0.265
L44.0 Pityriasis rubra pilaris
0.000 0.735 0.265
C94 Other leukaemias of specified cell type
0.001 0.736 0.264
L43.8 Other lichen planus
0.000 0.737 0.263
E28.2 Polycystic ovarian syndrome
0.000 0.738 0.262
E06.5 Other chronic thyroiditis
0.001 0.740 0.259
E06.4 Drug-induced thyroiditis
0.001 0.740 0.259
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.001 0.740 0.259
E06.0 Acute thyroiditis
0.001 0.740 0.259
C82.0 Small cleaved cell, follicular
0.000 0.741 0.258
E21.3 Hyperparathyroidism, unspecified
0.000 0.750 0.249
E26 Hyperaldosteronism
0.000 0.753 0.247
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.753 0.246
E32 Diseases of thymus
0.000 0.753 0.246
E31 Polyglandular dysfunction
0.000 0.753 0.246
E30 Disorders of puberty, not elsewhere classified
0.000 0.753 0.246
E25 Adrenogenital disorders
0.000 0.753 0.246
C84.0 Mycosis fungoides
0.000 0.754 0.246
E06.1 Subacute thyroiditis
0.001 0.755 0.244
C93 Monocytic leukaemia
0.001 0.756 0.243
E67 Other hyperalimentation
0.000 0.758 0.242
E68 Sequelae of hyperalimentation
0.000 0.758 0.242
C84.5 Other and unspecified T-cell lymphomas
0.000 0.763 0.237
E23.7 Disorder of pituitary gland, unspecified
0.000 0.764 0.236
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.765 0.234
E63 Other nutritional deficiencies
0.000 0.765 0.234
E50 Vitamin A deficiency
0.000 0.765 0.234
E60 Dietary zinc deficiency
0.000 0.765 0.234
E59 Dietary selenium deficiency
0.000 0.765 0.234
E54 Ascorbic acid deficiency
0.000 0.765 0.234
E52 Niacin deficiency [pellagra]
0.000 0.765 0.234
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.766 0.233
C81.3 Lymphocytic depletion
0.000 0.766 0.233
C81.2 Mixed cellularity
0.000 0.766 0.233
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.770 0.230
C81.7 Other Hodgkin's disease
0.000 0.771 0.229
C91 Lymphoid leukaemia
0.000 0.772 0.228
E61 Deficiency of other nutrient elements
0.000 0.772 0.228
E56 Other vitamin deficiencies
0.000 0.772 0.228
E58 Dietary calcium deficiency
0.000 0.776 0.224
E51 Thiamine deficiency
0.000 0.776 0.224
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.777 0.223
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.777 0.223
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.777 0.223
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.777 0.223
C84.3 Lymphoepithelioid lymphoma
0.000 0.777 0.223
C84.2 T-zone lymphoma
0.000 0.777 0.223
C84.1 Sezary's diease
0.000 0.777 0.223
C88 Malignant immunoproliferative diseases
0.001 0.778 0.221
C81.0 Lymphocytic predominance
0.000 0.779 0.221
E11.3 With ophthalmic complications
0.000 0.784 0.216
E23.2 Diabetes insipidus
0.000 0.787 0.212
E23.0 Hypopituitarism
0.000 0.790 0.210
E24.2 Drug-induced Cushing's syndrome
0.000 0.790 0.210
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.791 0.208
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.791 0.208
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.791 0.208
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.791 0.208
C86.4 Blastic NK-cell lymphoma
0.000 0.791 0.208
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.791 0.208
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.791 0.208
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.791 0.208
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.791 0.208
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.791 0.208
C96.8 Histiocytic sarcoma
0.000 0.791 0.208
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.791 0.208
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.791 0.208
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.791 0.208
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.791 0.208
C96.3 True histiocytic lymphoma
0.000 0.791 0.208
C96.2 Malignant mast cell tumour
0.000 0.791 0.208
C96.1 Malignant histiocytosis
0.000 0.791 0.208
C96.0 Letterer-Siwe disease
0.000 0.791 0.208
E28.9 Ovarian dysfunction, unspecified
0.000 0.792 0.208
E28.8 Other ovarian dysfunction
0.000 0.792 0.208
E28.1 Androgen excess
0.000 0.792 0.208
E28.0 Oestrogen excess
0.000 0.792 0.208
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.795 0.204
C84.4 Peripheral T-cell lymphoma
0.000 0.796 0.204
C91.9 Lymphoid leukaemia, unspecified
0.000 0.797 0.203
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.797 0.203
E23.1 Drug-induced hypopituitarism
0.000 0.797 0.203
E20 Hypoparathyroidism
0.000 0.799 0.201
E21.4 Other specified disorders of parathyroid gland
0.000 0.805 0.195
E21.2 Other hyperparathyroidism
0.000 0.805 0.195
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.807 0.193
C81.1 Nodular sclerosis
0.000 0.808 0.192
C83.0 Small cell (diffuse)
0.001 0.808 0.191
E24.8 Other Cushing's syndrome
0.000 0.809 0.190
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.809 0.190
E24.3 Ectopic ACTH syndrome
0.000 0.809 0.190
E24.1 Nelson's syndrome
0.000 0.809 0.190
E24.0 Pituitary-dependent Cushing's disease
0.000 0.809 0.190
E23.6 Other disorders of pituitary gland
0.000 0.809 0.190
E24.9 Cushing's syndrome, unspecified
0.000 0.809 0.190
C94.7 Other specified leukaemias
0.001 0.810 0.189
C94.5 Acute myelofibrosis
0.001 0.810 0.189
C94.4 Acute panmyelosis
0.001 0.810 0.189
C94.3 Mast cell leukaemia
0.001 0.810 0.189
C94.2 Acute megakaryoblastic leukaemia
0.001 0.810 0.189
C94.1 Chronic erythraemia
0.001 0.810 0.189
C94.0 Acute erythraemia and erythroleukaemia
0.001 0.810 0.189
C95 Leukaemia of unspecified cell type
0.001 0.817 0.182
E29 Testicular dysfunction
0.000 0.820 0.179
E55 Vitamin D deficiency
0.000 0.822 0.178
E26.0 Primary hyperaldosteronism
0.000 0.822 0.178
E65 Localised adiposity
0.000 0.822 0.177
E26.9 Hyperaldosteronism, unspecified
0.000 0.823 0.177
E26.8 Other hyperaldosteronism
0.000 0.823 0.177
E26.1 Secondary hyperaldosteronism
0.000 0.823 0.177
E25.9 Adrenogenital disorder, unspecified
0.000 0.823 0.177
E25.8 Other adrenogenital disorders
0.000 0.823 0.177
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.823 0.177
E30.9 Disorder of puberty, unspecified
0.000 0.823 0.177
E30.8 Other disorders of puberty
0.000 0.823 0.177
E30.1 Precocious puberty
0.000 0.823 0.177
E30.0 Delayed puberty
0.000 0.823 0.177
E31.9 Polyglandular dysfunction, unspecified
0.000 0.823 0.177
E31.8 Other polyglandular dysfunction
0.000 0.823 0.177
E31.1 Polyglandular hyperfunction
0.000 0.823 0.177
E31.0 Autoimmune polyglandular failure
0.000 0.823 0.177
E32.9 Disease of thymus, unspecified
0.000 0.823 0.177
E32.8 Other diseases of thymus
0.000 0.823 0.177
E32.1 Abscess of thymus
0.000 0.823 0.177
E32.0 Persistent hyperplasia of thymus
0.000 0.823 0.177
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.823 0.177
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.823 0.177
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.823 0.177
E28.3 Primary ovarian failure
0.000 0.824 0.176
C93.9 Monocytic leukaemia, unspecified
0.001 0.825 0.175
C93.7 Other monocytic leukaemia
0.001 0.825 0.175
C93.3 Juvenile myelomonocytic leukaemia
0.001 0.825 0.175
C93.2 Subacute monocytic leukaemia
0.001 0.825 0.175
C93.0 Acute monocytic leukaemia
0.001 0.825 0.175
E67.8 Other specified hyperalimentation
0.000 0.826 0.174
E67.3 Hypervitaminosis D
0.000 0.826 0.174
E67.2 Megavitamin-B6 syndrome
0.000 0.826 0.174
E67.1 Hypercarotenaemia
0.000 0.826 0.174
E67.0 Hypervitaminosis A
0.000 0.826 0.174
E22 Hyperfunction of pituitary gland
0.000 0.827 0.173
C92 Myeloid leukaemia
0.001 0.831 0.169
E61.1 Iron deficiency
0.000 0.831 0.169
E50.9 Vitamin A deficiency, unspecified
0.000 0.832 0.168
E50.8 Other manifestations of vitamin A deficiency
0.000 0.832 0.168
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.832 0.168
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.832 0.168
E50.5 Vitamin A deficiency with night blindness
0.000 0.832 0.168
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.832 0.168
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.832 0.168
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.832 0.168
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.832 0.168
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.832 0.168
E63.9 Nutritional deficiency, unspecified
0.000 0.832 0.168
E63.8 Other specified nutritional deficiencies
0.000 0.832 0.168
E63.1 Imbalance of constituents of food intake
0.000 0.832 0.168
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.832 0.168
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.832 0.168
E64.8 Sequelae of other nutritional deficiencies
0.000 0.832 0.168
E64.3 Sequelae of rickets
0.000 0.832 0.168
E64.2 Sequelae of vitamin C deficiency
0.000 0.832 0.168
E64.1 Sequelae of vitamin A deficiency
0.000 0.832 0.168
E64.0 Sequelae of protein-energy malnutrition
0.000 0.832 0.168
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.836 0.164
C91.7 Other lymphoid leukaemia
0.000 0.836 0.164
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.836 0.164
C91.3 Prolymphocytic leukaemia
0.000 0.836 0.164
C91.2 Subacute lymphocytic leukaemia
0.000 0.836 0.164
E61.9 Deficiency of nutrient element, unspecified
0.000 0.836 0.164
E61.8 Deficiency of other specified nutrient elements
0.000 0.836 0.164
E61.7 Deficiency of multiple nutrient elements
0.000 0.836 0.164
E61.6 Vanadium deficiency
0.000 0.836 0.164
E61.5 Molybdenum deficiency
0.000 0.836 0.164
E61.4 Chromium deficiency
0.000 0.836 0.164
E61.3 Manganese deficiency
0.000 0.836 0.164
E61.0 Copper deficiency
0.000 0.836 0.164
E56.9 Vitamin deficiency, unspecified
0.000 0.836 0.163
E56.8 Deficiency of other vitamins
0.000 0.836 0.163
E56.0 Deficiency of vitamin E
0.000 0.836 0.163

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.